1.Clinical characteristics of patients with psoriasis associated with metabolic syndrome
Juan CHENG ; Xueqin YANG ; Li ZHANG ; Fang LIU ; Rangsong HUI ; Lizhao WEI
Medical Journal of Chinese People's Liberation Army 1983;0(05):-
Objective To evaluate the prevalence of metabolic syndrome(MS) in patients with psoriasis,and explore the clinical features of the patients with metabolic syndrome-associated psoriasis.Methods Two hundred and two patients with psoriasis were investigated by face-to-face questionnaire,physical and laboratory examinations.Information included age,sex,the age of onset,duration of the disease,disease severity,family history,education level,waistline,fasting plasma glucose(FPG),triglyceride(TC),high-density lipoprotein cholesterol(HDL-C) and blood pressure(BP).The diagnosis of MS was established according to the criteria of International Diabetes Federation(IDF).Results ① Of 202 patients with psoriasis,45 suffered from metabolic syndrome,accounting for 22.27%.② The patients with metabolic syndrome-associated psoriasis always had significantly higher average age and the age of onset,longer disease history and severer symptoms than those psoriasis patients without metabolic syndrome(P0.05).③ The patients with metabolic syndrome-associated psoriasis had significantly longer waistline,fasting plasma glucose,triglyceride,blood pressure and lower high-density lipoprotein cholesterol than the psoriasis patients without metabolic syndrome(P0.05).Conclusion Metabolic syndrome is highly prevalent among the patients with psoriasis,which might be associated with smoking and drinking.
2.Correlation between 23 metals and metalloids elements in the urine and thyroid function of traffic police
Yaru WANG ; Chao QUAN ; Tian XYU ; Shuxia LIU ; Lizhao YANG ; Ling ZHANG ; Xiayun DAI
Journal of Public Health and Preventive Medicine 2024;35(2):25-29
Objective To investigate the correlation between 23 metals and metalloids elements in the urine and thyroid function indicators in the blood of traffic police. Methods A cross-sectional study was performed to assess the effects of 23 metals and metalloids elements in the urine on blood thyroid function indicators in 166 traffic policemen (122 field staff and 44 internal staff) in Wuhan, Hubei Province. Each subject received an occupational health examination. Results After multiple corrections for false detection rates, in the polymetallic model, the levels of urinary manganese and urinary uranium were positively correlated with the levels of thyroid peroxidase antibody (TPOAb) in the blood (β = 66.57, 95% CI 2.92-130.22, P = 0.040 and β = 62.43, 95% CI 14.37-110.49, P = 0.011), and the level of urinary uranium was positively correlated with thyroid stimulating hormone (TSH) levels in the blood (β = 6.20, 95% CI 2.68-9.72 , P = 0.001). Urinary uranium level was negatively correlated with free thyroxine level in the blood (FT4) (β = -2.03, 95 % CI (-3.67 )- (-0.39), P = 0.015), and urinary lead level was negatively correlated with blood TSH level (β = -4.59, 95% CI (-8.67) - (-0.51), P = 0.027). Conclusion Manganese exposure is related to the increase of TPOAb level in blood, uranium exposure is related to the increase of TPOAb and TSH levels and the decrease of FT4 level in blood, and lead exposure is related to the decrease of TSH level in blood, suggesting that more attention should be paid to the effects of heavy metals on the thyroid of traffic police.
3.CD133 epitope vaccine with gp96 as adjuvant elicits an antitumor T cell response against leukemia.
Shuo WANG ; Hongxia FAN ; Yang LI ; Huaguo ZHENG ; Xin LI ; Changfei LI ; Lizhao CHEN ; Ying JU ; Songdong MENG
Chinese Journal of Biotechnology 2017;33(6):1006-1017
Cancer stem cells are currently under intensive investigation due to their capabilities for tumor initiation, self-renewal, and resistance to chemotherapy. CD133 is implicated in stemness and the malignancy of tumor cells. Here, we explored heat shock protein gp96 adjuvanted CD133 epitope vaccine against leukemia. We screened and identified three H2-Kd-restricted cytotoxic T lymphocyte (CTL) epitopes derived from CD133, CD133₄₁₉₋₄₂₈, CD133₇₀₂₋₇₁₀ and CD133₇₆₀₋₇₆₉. The immunogenicity and antitumor activity of the epitope vaccine using heat shock protein gp96 as adjuvant were further determined in CD133⁺ leukemia xenograft mice. Finally, we demonstrate that adoptive transfer of epitope-specific CTLs led to suppression of leukemia growth. Our data therefore provide the basis for designing a CD133 epitope vaccine to activate specific CTLs against CD133⁺ leukemia and other cancers.